Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) price on Thursday, May 09, fall -15.64% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.85.
A look at the stock’s price movement, the level at last check in today’s session was $8.12. Turning to its 52-week performance, $15.70 and $7.53 were the 52-week high and 52-week low respectively. Overall, IRWD moved -14.27% over the past month.
Ironwood Pharmaceuticals Inc’s market cap currently stands at around $1.09 billion.
Analysts have a consensus estimate of 105.8M for the company’s revenue for the quarter, with a low and high estimate of 102.1M and 111.7M respectively. The average forecast suggests up to a 5.40% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 447.9M, representing a 1.20% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IRWD is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
IRWD’s current price about -14.23% and -19.66% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 27.75, while 7-day volatility ratio is 2.74% and 3.51% in the 30-day chart. Further, Ironwood Pharmaceuticals Inc (IRWD) has a beta value of 0.56, and an average true range (ATR) of 0.43.
If we refocus on Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), historical trading data shows that trading volumes averaged 4.51 million over the past 3 months. The company’s latest data on shares outstanding shows there are 156.35 million shares.
The 3.15% of Ironwood Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 102.52% of the company’s shares. Current price change has pushed the stock -40.12% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IRWD stock continues to rise going into the next quarter.
